Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Is The Adrenal Cancer Diagnostics Market Expected To Grow In Terms Of Size?

The market for diagnosing adrenal cancer has been experiencing robust growth in recent years. Its size is projected to increase from $140.35 billion in 2024 to $148.54 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.8%. The growth observed during the historic period is due to factors such as increased awareness and incidence of the disease, breakthroughs in genetic and molecular testing, improvements in biopsy techniques, advancements in endocrine testing, and the incorporation of artificial intelligence (AI).

The market size for diagnosing adrenal cancer is forecasted to exhibit robust growth in the coming years, reaching a value of $190.8 billion by 2029 with a compound annual growth rate (CAGR) of 6.5%. The expected growth during the forecast period can be credited to the adoption of personalized medicine, the increase in minimally invasive procedures, advancements in telemedicine and remote consultations, the progression of liquid biopsy, and the extension of genetic counseling services. Key trends anticipated during the forecast period encompass regulatory reinforcement for diagnostic innovations, the acceptance of digital pathology, progress in imaging technologies, the evolution of liquid biopsy, and genomic profiling for precision medicine.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13242&type=smp

What Are The Primary Factors Supporting The Adrenal Cancer Diagnostics Market Expansion?

The adrenal cancer diagnostics market is set to grow, spurred on by the increasing prevalence of cigarette smoking. Cigarette smoking involves the inhalation and exhalation of burnt tobacco fumes, which contain the addictive substance nicotine. This alkaloid can produce both stimulating and calming psychoactive effects. A correlation has been established between cigarette smoking and a heightened risk of adrenal cancer, including adrenal adenomas and adrenocortical carcinomas. The harmful substances in tobacco smoke have the potential to harm the DNA in adrenal cells, which can then mutate and lead to cancer. For example, Statistics Canada reported in July 2022 that there was a 5.8% rise in cigarette production when compared to June 2021. Moreover, the total cigarette sales increased by 1.3% from May 2022, hitting 1.4 billion in June 2022. Thus, the growth in the adrenal cancer diagnostics market can be attributed to the escalating trend of cigarette smoking.

Which Segmentation Categories Are Highlighted In The Adrenal Cancer Diagnostics Market Analysis?

The adrenal cancer diagnosticsmarket covered in this report is segmented –

1) By Test: Magnetic Resonance Imaging (MRI); Computed Tomography (CT) Scan; X-ray; Positron Emission Tomography (PET) Scan; Biopsy

2) By Treatment: Surgery; Chemotherapy; Radiotherapy; Targeted Cancer Therapies; Other Treatments

3) By Tumor Type: Pheochromocytoma; Adrenal Cortical Carcinoma; Other Types

4) By End-User: Hospitals; Ambulatory Surgical Centers; Cancer Centers; Other End-Users

Subsegments:

1) By Magnetic Resonance Imaging (MRI): Contrast-Enhanced MRI; Functional MRI

2) By Computed Tomography (CT) Scan: Contrast-Enhanced CT; Abdomen And Pelvis CT Scans

3) By X-ray: Standard X-ray Imaging; Specialized X-ray Techniques

4) By Positron Emission Tomography (PET) Scan: PET-CT Combination Scans; Standalone PET Scans

5) By Biopsy: Fine Needle Aspiration Biopsy (FNA); Core Needle Biopsy; Surgical Biopsy

Which Trends Are Likely To Redefine Growth Paths In The Adrenal Cancer Diagnostics Market?

Major firms in the adrenal cancer diagnostics market are focusing on innovative development and advanced partnership approaches like the CancerX Startup Accelerator to boost digital advancements in oncology care. The goal of the Accelerator is to offer handpicked startups the mentorship, training, and a direct path to key healthcare industry players such as institutional providers and pharmaceutical firms. For example, CanceRx, LLC, a US-based alliance between public and private sectors to ramp up innovation in cancer combat, announced the inauguration of this program at the Future of Cancer Care Summit in Tampa, Florida, in November 2023. Starting in March 2024, the program will select its first group of around 15 to 20 companies, concentrating on vital aspects such as clinical study, screening, diagnosis, and therapy. It aims to propel the objectives of the Cancer Moonshot initiative significantly by addressing the gaps in cancer care and promoting the creation of efficient digital health tools in oncology.

Which Organizations Are At The Forefront Of The Adrenal Cancer Diagnostics Market?

Major companies operating in the adrenal cancer diagnostics market report are Johnson And Johnson Pvt Ltd., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, GSK PLC, AstraZeneca PLC, Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson and Company, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies, Hologic Inc., PerkinElmer Inc., Illumina Inc., Roche Diagnostics, BioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Exact Sciences Corp., Natera Inc., Invitae Corporation, Qiagen NV, Guardant Health Inc., Foundation Medicine Inc., NanoString Technologies Inc., TRS Technologies Inc., Morgan Advanced Materials, APC International Ltd., Annon Piezo Technology Co. Limited

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/adrenal-cancer-diagnostics-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Adrenal Cancer Diagnostics Market?

North America was the largest region in the adrenal cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adrenal cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=13242&type=smp

Browse Through More Reports Similar to the Global Adrenal Cancer Diagnostics Market 2025, By The Business Research Company

Breast Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/breast-cancer-drugs-global-market-report

Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Cervical Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cervical-cancer-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model